» Articles » PMID: 21827449

Genistein Aglycone, a Soy-derived Isoflavone, Improves Skin Changes Induced by Ovariectomy in Rats

Overview
Journal Br J Pharmacol
Publisher Wiley
Specialty Pharmacology
Date 2011 Aug 11
PMID 21827449
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Purpose: Ovariectomy accelerates age-related skin changes as adequate oestrogen levels are required to control structural integrity and functional capacity of skin. Genistein, a soy-derived isoflavone, has been tested in anti-ageing cosmetic preparations with interesting results on skin elasticity, photoaging and skin cancer prevention. We investigated the effects of genistein aglycone and compared them with systemic raloxifene hydrochloride and 17-α-ethinyloestradiol on skin changes in aged, ovariectomized (OVX) rats.

Experimental Approach: Six months after ovariectomy, rats were randomly allocated to different groups and treated, daily, with genistein aglycone (1 and 10mg·kg(-1) s.c.), raloxifene hydrochloride (0.05 and 0.5mg·kg(-1) s.c.) or 17-α-ethinyloestradiol (0.003 and 0.03mg·kg(-1) s.c.) for 12 weeks. Controls were untreated OVX and sham OVX rats. At the end of the treatment period, a skin biopsy was carried out and skin samples were assessed for molecular, histological and functional changes.

Key Results: Skin samples of untreated OVX rats showed a decrease in TGF-β1, VEGF, MMP-2, MMP-9, tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2 compared with sham OVX rats. All the treatments significantly restored this depressed molecular profile revealed in OVX rats. Genistein aglycone, 1mg·kg(-1) , also significantly increased the thickness of collagen and breaking strength of skin in the OVX rats.

Conclusions And Implications: Relatively long-term, systemic treatment with genistein aglycone shows comparable efficacy to oestrogen in reversing some molecular, histological and functional changes of the skin associated with ovariectomy in aged rats. This suggests that genistein aglycone might be an effective alternative therapy for the management of age-related skin changes in postmenopausal women.

Citing Articles

The Therapeutic Role of Genistein in Perimenopausal and Postmenopausal Women.

Nestor M, Bhupalam V, Awad N, Hetzel J J Clin Aesthet Dermatol. 2024; 17(10):45-53.

PMID: 39445324 PMC: 11495164.


ROS Scavenging Effect of Selected Isoflavones in Provoked Oxidative Stress Conditions in Human Skin Fibroblasts and Keratinocytes.

Wojciak M, Drozdowski P, Ziemlewska A, Zagorska-Dziok M, Niziol-Lukaszewska Z, Kubrak T Molecules. 2024; 29(5).

PMID: 38474467 PMC: 10934730. DOI: 10.3390/molecules29050955.


An extensive review on phenolic compounds and their potential estrogenic properties on skin physiology.

Rispo F, De Negri Atanasio G, Demori I, Costa G, Marchese E, Perera-Del-Rosario S Front Cell Dev Biol. 2024; 11:1305835.

PMID: 38250328 PMC: 10798251. DOI: 10.3389/fcell.2023.1305835.


Extraction of Isoflavones, Alpha-Hydroxy Acids, and Allantoin from Soybean Leaves-Optimization by a Mixture Design of the Experimental Method.

Dresler S, Strzemski M, Baczewska I, Koselski M, Hassanpouraghdam M, Szczepanek D Molecules. 2023; 28(9).

PMID: 37175385 PMC: 10179801. DOI: 10.3390/molecules28093963.


Particle Nanoarchitectonics for Nanomedicine and Nanotherapeutic Drugs with Special Emphasis on Nasal Drugs and Aging.

Aziz T, Ali Nadeem A, Sarwar A, Perveen I, Hussain N, Khan A Biomedicines. 2023; 11(2).

PMID: 36830891 PMC: 9953552. DOI: 10.3390/biomedicines11020354.


References
1.
Chung J, Eun H . Angiogenesis in skin aging and photoaging. J Dermatol. 2007; 34(9):593-600. DOI: 10.1111/j.1346-8138.2007.00341.x. View

2.
Merlo S, Frasca G, Canonico P, Sortino M . Differential involvement of estrogen receptor alpha and estrogen receptor beta in the healing promoting effect of estrogen in human keratinocytes. J Endocrinol. 2008; 200(2):189-97. DOI: 10.1677/JOE-08-0442. View

3.
Bitto A, Burnett B, Polito F, Marini H, Levy R, Armbruster M . Effects of genistein aglycone in osteoporotic, ovariectomized rats: a comparison with alendronate, raloxifene and oestradiol. Br J Pharmacol. 2008; 155(6):896-905. PMC: 2515927. DOI: 10.1038/bjp.2008.305. View

4.
Kahari V, Saarialho-Kere U . Matrix metalloproteinases and their inhibitors in tumour growth and invasion. Ann Med. 1999; 31(1):34-45. DOI: 10.3109/07853899909019260. View

5.
Squadrito F, Altavilla D, Crisafulli A, Saitta A, Cucinotta D, Morabito N . Effect of genistein on endothelial function in postmenopausal women: a randomized, double-blind, controlled study. Am J Med. 2003; 114(6):470-6. DOI: 10.1016/s0002-9343(03)00059-7. View